Amgen

Amgen Italia is a biotechnology leader dedicated to combating serious illnesses by developing innovative therapies that extend and improve patients' lives. With over 40 years of pioneering work, the company leverages cutting-edge R&D to create advanced therapeutics for critical health issues like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's mission is to serve patients by translating scientific breakthroughs into life-enhancing treatments, guided by strong values and a patient-centric approach.

Operating within the Pharmaceutical and Healthcare sectors, Amgen Italia employs 500-1,000 professionals and generates $47.5M in revenue, indicating significant operational scale. Its commitment to scientific advancement is evident in robust R&D efforts to discover novel solutions. For insights into the individuals driving these innovations, one can Meet Amgen's team. This dedicated team works collaboratively to push the boundaries of biotechnology and ensure the development of effective treatments for complex diseases.

Amgen Italia's strategic operations are rooted in Italy, with a global vision for equitable access to its medications. Its B2B focus and presence within the European market are supported by dedication to scientific rigor and patient well-being. By concentrating on serious illnesses, Amgen aims to make a profound impact on public health, particularly in areas like oncology and autoimmune conditions, improving quality of life for patients worldwide.